• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚、菲律宾和新加坡肺癌负担的估计:伤残调整生命年评估

Estimation of lung cancer burden in Australia, the Philippines, and Singapore: an evaluation of disability adjusted life years.

作者信息

Morampudi Suman, Das Neha, Gowda Arun, Patil Anand

机构信息

Phamax Analytic Resources Pvt. Ltd., Bengaluru 560095, India.

出版信息

Cancer Biol Med. 2017 Feb;14(1):74-82. doi: 10.20892/j.issn.2095-3941.2016.0030.

DOI:10.20892/j.issn.2095-3941.2016.0030
PMID:28443206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5365184/
Abstract

OBJECTIVE

Lung cancer is one of the leading cancers and major causes of cancer mortality worldwide. The economic burden associated with the high mortality of lung cancer is high, which accounts for nearly $180 billion on a global scale in 2008. This paper aims to understand the economic burden of lung cancer in terms of disability adjusted life years (DALY) in Australia, the Philippines, and Singapore.

METHODS

The years of life lost (YLL) and years lost due to disability (YLD) were calculated using the formula developed by Murray and Lopez in 1996 as part of a comprehensive assessment of mortality and disability for diseases, injuries and risk factors in 1990 and projected to 2020. The same formula is represented in the Global Burden of Disease template provided by the World Health Organization. Appropriate assumptions were made when data were unavailable and projections were performed using regression analysis to obtain data for 2015.

RESULTS

The total DALYs due to lung cancer in Australia, the Philippines, and Singapore were 91,695, 38,584, and 12,435, respectively, and the corresponding DALY rates per a population of 1,000 were 4.0, 0.4, and 2.2, respectively, with a discount rate of 3%. When researchers calculated DALYs without the discount rate, the burden of disease increased substantially; the DALYs were 117,438 in Australia, 50,977 in the Philippines, and 16,379 in Singapore. Overall, YLL or premature death accounted for more than 95% of DALYs in these countries.

CONCLUSIONS

Strategies for prevention, early diagnosis, and prompt treatment must be devised for diseases where the major burden is due to mortality.

摘要

目的

肺癌是全球主要癌症之一及癌症死亡的主要原因。与肺癌高死亡率相关的经济负担沉重,2008年在全球范围内接近1800亿美元。本文旨在从残疾调整生命年(DALY)角度了解澳大利亚、菲律宾和新加坡肺癌的经济负担。

方法

使用默里和洛佩兹于1996年制定的公式计算寿命损失年数(YLL)和因残疾损失年数(YLD),作为1990年疾病、损伤及风险因素死亡率和残疾率综合评估的一部分,并预测至2020年。世界卫生组织提供的全球疾病负担模板中也采用了相同公式。数据不可用时进行了适当假设,并使用回归分析进行预测以获取2015年的数据。

结果

澳大利亚、菲律宾和新加坡因肺癌导致的DALY总数分别为91,695、38,584和12,435,相应的每千人口DALY率分别为4.0、0.4和2.2,贴现率为3%。当研究人员不采用贴现率计算DALY时,疾病负担大幅增加;澳大利亚的DALY为117,438,菲律宾为50,977,新加坡为16,379。总体而言这些国家YLL或过早死亡占DALY的95%以上。

结论

对于主要负担源于死亡率的疾病,必须制定预防、早期诊断和及时治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/0ab7da50ac7a/cbm-14-1-74-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/5da01cc6eec5/cbm-14-1-74-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/ca7055cd87c0/cbm-14-1-74-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/0ab7da50ac7a/cbm-14-1-74-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/5da01cc6eec5/cbm-14-1-74-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/ca7055cd87c0/cbm-14-1-74-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e58/5365184/0ab7da50ac7a/cbm-14-1-74-3.jpg

相似文献

1
Estimation of lung cancer burden in Australia, the Philippines, and Singapore: an evaluation of disability adjusted life years.澳大利亚、菲律宾和新加坡肺癌负担的估计:伤残调整生命年评估
Cancer Biol Med. 2017 Feb;14(1):74-82. doi: 10.20892/j.issn.2095-3941.2016.0030.
2
Singapore's burden of disease and injury 2004.新加坡 2004 年疾病与损伤负担
Singapore Med J. 2009 May;50(5):468-78.
3
[The current status and trend of disease burden of neoplasms in 1990 and 2016 for Beijing people].[1990年和2016年北京居民肿瘤疾病负担的现状及趋势]
Zhonghua Zhong Liu Za Zhi. 2021 Mar 23;43(3):351-356. doi: 10.3760/cma.j.cn112152-20190416-00239.
4
[The disease burden of cardiovascular and circulatory diseases in China, 1990 and 2010].[1990年和2010年中国心血管和循环系统疾病的疾病负担]
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Apr;49(4):315-20.
5
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe.与欧洲 COVID-19 相关的黑色素瘤诊断延迟相关的健康经济后果。
JAMA Netw Open. 2024 Feb 5;7(2):e2356479. doi: 10.1001/jamanetworkopen.2023.56479.
6
[Evaluation of the burden of diabetes in Poland].[波兰糖尿病负担评估]
Pol Arch Med Wewn. 2001 Sep;106(3):867-73.
7
Burden of ischemic heart diseases in Iran, 1990-2010: Findings from the Global Burden of Disease study 2010.1990 - 2010年伊朗缺血性心脏病负担:全球疾病负担研究2010的结果
J Res Med Sci. 2015 Nov;20(11):1077-83. doi: 10.4103/1735-1995.172832.
8
Estimation of Burden of Cystic Echinococcosis in Iran Using Disability Adjusted Life Years (DALYs) in 2018.2018年利用伤残调整生命年(DALYs)对伊朗囊型包虫病负担的估计。
Iran J Public Health. 2021 Nov;50(11):2302-2308. doi: 10.18502/ijph.v50i11.7586.
9
Disability adjusted life years for cancer patients in India.印度癌症患者的伤残调整生命年
Asian Pac J Cancer Prev. 2010;11(3):633-40.
10
[Disease burden of prostate cancer among men in China, from 1990 to 2013].1990年至2013年中国男性前列腺癌疾病负担
Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Jun;37(6):778-82. doi: 10.3760/cma.j.issn.0254-6450.2016.06.007.

引用本文的文献

1
Acupuncture for Chronic Obstructive Pulmonary Disease: A 38-Year Bibliometric Landscape of Global Research Trends and Knowledge Evolution (1986-2024).针灸治疗慢性阻塞性肺疾病:1986 - 2024年全球研究趋势与知识演进的38年文献计量学图景
Int J Chron Obstruct Pulmon Dis. 2025 Jul 14;20:2393-2408. doi: 10.2147/COPD.S531611. eCollection 2025.
2
Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper.澳大利亚和新西兰肺癌临床质量登记处的建立:研究方案。
BMJ Open. 2022 Aug 29;12(8):e060907. doi: 10.1136/bmjopen-2022-060907.
3
Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018.

本文引用的文献

1
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.
2
Smoking-attributable burden of lung cancer in the Philippines.菲律宾肺癌的吸烟归因负担。
Tob Control. 2015 May;24(3):263-8. doi: 10.1136/tobaccocontrol-2013-051082. Epub 2014 Jan 8.
3
Cancer trends and incidences in Singapore.新加坡癌症趋势和发病率。
2018年印度尼西亚宫颈癌死亡率相关生产力成本预测
Malays J Med Sci. 2022 Feb;29(1):138-144. doi: 10.21315/mjms2022.29.1.13. Epub 2022 Feb 23.
4
Analyzing the Changes in Certain Infectious and Parasitic Diseases in Urban Population of India By Using Medical Certification of Cause of Death Data.利用死因医学证明数据分析印度城市人口中某些传染病和寄生虫病的变化情况。
Indian J Community Med. 2021 Jan-Mar;46(1):20-23. doi: 10.4103/ijcm.IJCM_77_20. Epub 2021 Mar 1.
5
The temporal trend and distribution characteristics in mortality of Alzheimer's disease and other forms of dementia in China: Based on the National Mortality Surveillance System (NMS) from 2009 to 2015.中国阿尔茨海默病和其他类型痴呆死亡率的时间趋势和分布特征:基于 2009 年至 2015 年国家死亡监测系统(NMS)。
PLoS One. 2019 Jan 31;14(1):e0210621. doi: 10.1371/journal.pone.0210621. eCollection 2019.
6
The utilisation of convolutional neural networks in detecting pulmonary nodules: a review.卷积神经网络在肺结节检测中的应用:综述
Br J Radiol. 2018 Oct;91(1090):20180028. doi: 10.1259/bjr.20180028. Epub 2018 Jun 19.
Jpn J Clin Oncol. 2013 Mar;43(3):219-24. doi: 10.1093/jjco/hys230. Epub 2013 Jan 9.
4
Global estimates of cancer prevalence for 27 sites in the adult population in 2008.2008 年全球 27 个成人部位癌症发病估计数。
Int J Cancer. 2013 Mar 1;132(5):1133-45. doi: 10.1002/ijc.27711. Epub 2012 Jul 26.
5
The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN).东南亚国家联盟(东盟)成员国的癌症负担。
Asian Pac J Cancer Prev. 2012;13(2):411-20. doi: 10.7314/apjcp.2012.13.2.411.
6
Singapore's burden of disease and injury 2004.新加坡 2004 年疾病与损伤负担
Singapore Med J. 2009 May;50(5):468-78.
7
Cancer and the Philippine Cancer Control Program.癌症与菲律宾癌症控制项目
Jpn J Clin Oncol. 2002 Mar;32 Suppl:S52-61. doi: 10.1093/jjco/hye126.
8
Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.在成本效益分析中计算并呈现伤残调整生命年(DALYs)
Health Policy Plan. 2001 Sep;16(3):326-31. doi: 10.1093/heapol/16.3.326.
9
Panel on cost-effectiveness in health and medicine.卫生与医学成本效益专题小组。
Med Care. 1996 Dec;34(12 Suppl):DS197-9.
10
Quantifying the burden of disease: the technical basis for disability-adjusted life years.疾病负担的量化:伤残调整生命年的技术基础。
Bull World Health Organ. 1994;72(3):429-45.